JavaScript is disabled in your browser. Please enable JavaScript to view this website.

PROM1

GeneName

PROM1

Summary

PROM1, also known as CD133 or prominin-1, is a 97 kDa glycoprotein that is predominantly localised to the apical plasma membrane of various cell types, including stem cells and retinal photoreceptors. It plays a crucial role in the maintenance and differentiation of photoreceptor cells in the retina, as well as in the differentiation of glomerular parietal epithelial cells and podocytes. PROM1 is associated with cellular structures such as microvilli and cilia, and is involved in cholesterol binding and cell adhesion through its interactions with actin and cadherins. Its presence in extracellular exosomes suggests a role in intercellular communication and signalling.

Importance

PROM1 is relevant to: - Stem cell biology, as it serves as a marker for various stem and progenitor cell populations - Retinal diseases, given its involvement in photoreceptor cell maintenance and differentiation, which is critical for vision - Kidney development and function, due to its role in podocyte differentiation and nephron tubule epithelial cell differentiation - Potential therapeutic targets in regenerative medicine and cancer, as it is implicated in tumour initiation and progression in certain cancers.

Top Products

For researchers investigating PROM1, we recommend two excellent primary antibodies. The first is the well-cited polyclonal antibody, Anti-CD133 antibody - Stem Cell Marker (ab19898), which has garnered 314 citations, underscoring its reliability in Western blotting (WB). Additionally, we offer the recombinant antibody, Anti-CD133 antibody [EPR16508] (ab222782), which has been validated in knockout models and is suitable for both WB and immunohistochemistry (IHC). With 50 citations, this recombinant product provides the batch-to-batch consistency that many researchers seek, making it a strong choice for PROM1 studies.

Abcam Product Citation Summary

The data indicates a significant focus on the role of PROM1 in various human cancers, particularly prostate cancer, colorectal carcinoma, and liver cancer. The use of multiple applications, including immunohistochemistry, immunofluorescence, and Western blotting, highlights the versatility of Abcam antibodies in studying PROM1 across different experimental contexts. Additionally, the involvement of PROM1 in stem cell research and tumor biology suggests its potential as a therapeutic target.

Abcam Product Citation Table

Product Code
Species
Application
Study Context
PMID
ab19898
Human
IHC, IF
Prostate cancer cells
22359577
ab19898
Human
ICC, IF
Umbilical stem cells
26654529
ab19898
Human
IHC
Colorectal carcinoma
30221090
ab19898
Rat
IF
Myocardial infarction
30705637
ab19898
Rat
Flow Cytometry
Effects of VO-OHpic on EPCs viability
32228695
ab19898
Human
WB
Cell proliferation and apoptosis
32698859
ab19898
Human
WB
Esophageal squamous cell carcinoma
32698859
ab19898
Human
WB, ICC, IF
Rhabdomyosarcoma cells
25977066
ab19898
Human
WB
Human cell lines
26020117
ab19898
Human
IF, IHC
Tumor endothelial cells
28415725
ab19898
Human
IF, IHC
PCNSL tumor vessels
28415725
ab216323
Human
WB
Liver cancer stem cells
30326936
ab216323
Human
WB
Liver cancer stem cells
30326936
ab216323
Human
WB
Stem cell formation and proliferation
31130822
ab216323
Human
WB
SGC7901 cells
31130822
ab216323
Human
WB
Tumorigenicity in SGC7901 cells
31130822
ab222782
Human
WB
Therapeutic resistance
37173968

Function

May play a role in cell differentiation, proliferation and apoptosis (PubMed:24556617). Binds cholesterol in cholesterol-containing plasma membrane microdomains and may play a role in the organization of the apical plasma membrane in epithelial cells. During early retinal development acts as a key regulator of disk morphogenesis. Involved in regulation of MAPK and Akt signaling pathways. In neuroblastoma cells suppresses cell differentiation such as neurite outgrowth in a RET-dependent manner (PubMed:20818439).

Involvement in disease

Retinitis pigmentosa 41

RP41

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

None

The disease is caused by variants affecting the gene represented in this entry.

Cone-rod dystrophy 12

CORD12

An inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa, due to cone photoreceptors degenerating at a higher rate than rod photoreceptors.

None

The disease is caused by variants affecting the gene represented in this entry.

Stargardt disease 4

STGD4

A common hereditary macular degeneration. It is characterized by decreased central vision, atrophy of the macula and underlying retinal pigment epithelium, and frequent presence of prominent flecks in the posterior pole of the retina.

None

The disease is caused by variants affecting the gene represented in this entry.

Macular dystrophy, retinal, 2

MCDR2

An autosomal dominant retinal disease characterized by dyschromatopsia, gradual progressive loss of central visual acuity, and bilateral annular atrophy of retinal pigment epithelium at the macula.

None

The disease is caused by variants affecting the gene represented in this entry.

Post-translational modifications

Isoform 1 and isoform 2 are glycosylated.

Acetylation at Lys-225, Lys-257 and Lys-264 by NAT8 and NAT8B may control PROM1 protein expression and its function in cell apoptosis.

Sequence Similarities

Belongs to the prominin family.

Tissue Specificity

Isoform 1 is selectively expressed on CD34 hematopoietic stem and progenitor cells in adult and fetal bone marrow, fetal liver, cord blood and adult peripheral blood. Isoform 1 is not detected on other blood cells. Isoform 1 is also expressed in a number of non-lymphoid tissues including retina, pancreas, placenta, kidney, liver, lung, brain and heart. Found in saliva within small membrane particles. Isoform 2 is predominantly expressed in fetal liver, skeletal muscle, kidney, and heart as well as adult pancreas, kidney, liver, lung, and placenta. Isoform 2 is highly expressed in fetal liver, low in bone marrow, and barely detectable in peripheral blood. Isoform 2 is expressed on hematopoietic stem cells and in epidermal basal cells (at protein level). Expressed in adult retina by rod and cone photoreceptor cells (at protein level).

Cellular localization

Alternative names

CD133, PROML1, MSTP061, PROM1, Prominin-1, Antigen AC133, Prominin-like protein 1

swissprot:O43490 entrezGene:8842 omim:604365

Other research areas